A major global survey of recent antibiotic users found that many people are concerned about antibiotic resistant dis-ease strains. However, the study also found that few respon-dents realized that using left-over drugs, from an uncom-pleted previous course of treatment, was a contributory factor in the emergence of drug-resistant bacteria. Based on these findings, which were sponsored by global drug giant Pfizer and presented at the European Congress of Clinical Microbiology and Infectious Diseases in Nice, France, earlier this month, the expert committee over-seeing the survey proposed a series of tailored antibiotic education campaigns to encourage proper use of the drugs.
The Compliance, Modalities by Population, Lifestyle and Geography Study (COMPLy) was carried out by the Gallup Organization during late 2005. A combination of face-to-face and telephone interviews was conducted with 4,500 respondents in 11 countries: Brazil, China, Italy, Japan, Mexico, the Netherlands, the Philippines, Russia, South Africa, Turkey and the USA.
"Creating an ideal environment for bacteria"
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze